<DOC>
	<DOCNO>NCT00646165</DOCNO>
	<brief_summary>To determine dose duration treatment best overall response Forodesine relapse B-cell chronic lymphocytic leukemia</brief_summary>
	<brief_title>Trial Forodesine Patients With Relapsed B-cell Chronic Lymphocytic Leukemia</brief_title>
	<detailed_description>An open label , multi centre , three arm , dose find Phase 1 trial Forodesine single drug treatment patient relapse CLL establish dose duration treatment result best achievable response Forodesine single drug treatment .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<criteria>Patients confirm Binet Stage B C BCLL define National Cancer Institute ( NCI ) sponsor work group receive 2 previous line treatment , one fludarabine base . The two previous treatment could include combination therapy . Patients must ≥18 year age , life expectancy &gt; 6 month , Eastern Cooperative Oncology Group ( ECOG ) performance status 0 , 1 , 2 . Female patient must pregnant ( confirm negative pregnancy test woman childbearing potential ) female male patient must willing use effective contraception entire duration treatment 2 month thereafter . Patients receive 2 previous line treatment exclude study . Additional group patient may participate study include : patient pregnant and/or nursing ; patient corticosteroid treatment ; patient active infection ( bacterial , viral fungal ) severe infection ( WHO 4th degree ) within last 3 month ; patient total bilirubin &gt; 2 × ULN ; patient calculate creatinine clearance &lt; 70 mL/min ; patient seropositivity human immunodeficiency virus , hepatitis B virus , hepatitis C virus ; patient coexist medical psychological condition would preclude participation require study procedure ; patient participate another clinical study &lt; 6 week prior study ; patient know hypersensitivity study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Leukemia , CLL</keyword>
</DOC>